Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91%. While colonoscopy remains the gold ...
UPPSALA, Sweden, May 30, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today reported the publication of a landmark study using the Olink Explore platform to identify proteins in the blood ...
UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today announced the introduction of Olink ® Explore HT, a transformational solution for high-throughput proteomics ...
Olink Reveal is more than a proteomics kit—it’s a gateway for anyone starting with proteomics. Whether profiling the reactome or interrogating inflammation biomarkers, validating clinical targets, or ...
Thermo Fisher Scientific TMO recently announced the launch of the Olink Target 48 Neurodegeneration panel — a high-performance, targeted proteomics immunoassay panel developed to accelerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results